- QMRO Home
- Blizard Institute
- Centre for Immunobiology
- An Open-Label Trial of 12-Week Simeprevir plus Peginterferon/Ribavirin (PR) in Treatment-Naive Patients with Hepatitis C Virus (HCV) Genotype 1 (GT1)
Browse
Administrators only